FilingReader Intelligence

C-MER Eye Care announces leadership transition effective June 1

May 23, 2025 at 05:05 PM UTC•By FilingReader AI

C-MER Medical Holdings Limited (HKEX:3309) has announced a significant leadership restructuring, effective June 1, 2025. Dr. Lam Shun Chiu Dennis, the current Chairman, Executive Director, and Chief Executive Officer, will resign from these positions to focus on clinical work and ophthalmic innovation, remaining with the company as an ophthalmologist and senior advisor. Dr. Rex Auyeung Pak-kuen, currently Vice Chairman, will assume the role of Chairman, while Ms. LI Xiaoting is appointed Vice Chairman and Chief Executive Officer.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

Primary Source Document

(1) RESIGNATION OF CHAIRMAN OF THE BOARD, EXECUTIVE DIRECTOR AND CHIEF EXECUTIVE OFFICER; (2) APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTORS AND VICE CHAIRMAN; (3) APPOINTMENT OF CHAIRMAN, VICE CHAIRMAN AND CHIEF EXECUTIVE OFFICER; (4) CHANGE OF COMMITTEE MEMBERS AND (5) CONTINUING CONNECTED TRANSACTION IN RESPECT OF OPHTHALMOLOGIST AND SENIOR ADVISOR SERVICE AGREEMENT OF DR. LAM SHUN CHIU DENNISMay 23, 2025 at 11:12 AM UTC

C-MER Eye Care Holdings

HKEX:3309•Hong Kong Exchange

RSS feed for C-MER Eye Care Holdings

News Alerts

Get instant email alerts when C-MER Eye Care Holdings publishes news

Free account required • Unsubscribe anytime

Browse RSS Feeds

Filing Activity Timeline

View Complete Filing History →